ClinicalTrials.Veeva

Menu

Continuous Wireless Monitoring in Internal Medicine Unit: the Green Line From Hospital to Territory (GreenLightHT)

A

Azienda Socio Sanitaria Territoriale del Garda

Status

Unknown

Conditions

Patient Monitoring

Treatments

Device: Vital signs wireless monitoring system

Study type

Interventional

Funder types

Other

Identifiers

NCT03764709
Green Light HT 2018

Details and patient eligibility

About

Study Information Indication* This is a prospective, randomized, controlled, open-label, monocentric study for the evaluation of two different settings of critically ill patients recovered in Internal Medicine unit (IMU) and subsequently sent to subacute managed care unit or to earlier discharge, in order to evaluate the effectiveness of a wireless monitoring of clinical conditions vs. a traditional clinical monitoring on outcomes (critical adverse events, clinical exacerbations).

Phase*: 4, observational prospective

Number of subjects*:

GROUP A and GROUP B: N=300 patients (150 per arm)

Full description

Background and Rationale* In IMU there is an increasing concentration of patients with serious illness, under acute exacerbation of previous diseases, elderly patients with co-morbidities and/or fragility, needing high intensity care. Those patients need an overall evaluation of the rank of severity, complexity and dependence of their pathology, together with an evaluation of their risk of clinical deterioration, to implement a stratification of optimal treatments, intensity of care, length of stay. This could allow to optimize the approach to the complexity of the patients while helping containing costs, not only on the patients who are evaluated during their stay in IMUs, but also in those patients who undergo protected hospital discharge or transition to subacute intensive care unit.

Objectives*

Some preliminary data on wireless monitoring in IMU have shown that the timely identification of clinical instability could led to a shorter length of stay. Monitoring on clinically unstable patients lets to prevent the deterioration of adverse events, thus allowing a rapid onset of intervention. There are some expected outcomes following the adoption of a wireless clinical monitoring system:

  1. Shorter length of stay and earlier discharge
  2. Lower transition rate to Intensive Care Unit (ICU)
  3. Earlier transition of patients from higher to lower intensity of care
  4. Shorter time needed by nurses for the detection of vital signs and clinical parameters, and possibility to dedicate to high-quality activities

Therefore the present study aims to provide data regarding the impact of a specific and oriented integrated remote system for the monitoring of vital status of critically ill patients in the improvement of outcomes and in a more efficient prevision of length of stay and costs, and to verify whether the regular use of a wireless remote monitoring system could improve the quality of the assistance and reduce major complications vs. a traditional monitoring of clinical status executed by the nursing staff, in two specific settings of critically ill patients referring to Internal Medicine with acute conditions:

GROUP A: Patients who undergo a transition to a subacute intensive care unit, in terms of reduction of re-exacerbation, re-access to emergency department or need of intervention by Internal Medicine unit specialists by the use of wireless monitoring vs. traditional monitoring.

GROUP B: Patients who are selected for an earlier discharge from Internal Medicine Unit, in terms of non-inferiority in the incidence of major clinical complications.

Enrollment

300 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. All patients admitted to the Internal Medicine Unit regardless of the reason for admission.

    2. For GROUP A: eligibility to the transition towards subacute managed care unit (based on clinical evaluation).

    3. For GROUP B: eligibility to early discharge based on clinical evaluation and stable MEWS/NEWS scores.

Exclusion criteria

    • Inability to discernment
  • Lack of informed consent/unwillingness to participate
  • MEWS/NEWS out of range
  • Transition to rehabilitation, Hospice, RSA or other Acute unit
  • Pacemaker carriers

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 4 patient groups

Vital signs wireless monitoring system GROUP A
Experimental group
Description:
GROUP A clinical hypothesis: reduction in the number of exacerbations in stable inpatients who transit towards subacute managed care unit. The experimental arm will wear wireless monitoring for 5 days after transfer in subacute care unit
Treatment:
Device: Vital signs wireless monitoring system
Control arm GROUP A
Active Comparator group
Description:
GROUP A clinical hypothesis: reduction in the number of exacerbations in stable inpatients who transit towards subacute managed care unit. The active comparator arm will be monitored by nursing staff.
Treatment:
Device: Vital signs wireless monitoring system
Vital signs wireless monitoring system GROUP B
Experimental group
Description:
GROUP B clinical hypothesis: non-inferiority in the number of major clinical complications that, if treated at an earlier stage, can improve outcomes in stable patients who are selected for earlier discharge and are followed by a remote wireless monitoring at home. The experimental arm will wear wireless monitoring for 5 days after discharge at home
Treatment:
Device: Vital signs wireless monitoring system
Control Arm GROUP B
Active Comparator group
Description:
GROUP B clinical hypothesis: non-inferiority in the number of major clinical complications that, if treated at an earlier stage, can improve outcomes in stable patients who are selected for earlier discharge and are followed by a remote wireless monitoring at home. The active comparator arm will perform usual checks by caregivers at home.
Treatment:
Device: Vital signs wireless monitoring system

Trial contacts and locations

1

Loading...

Central trial contact

Filomena Pietrantonio, MD; Antonella Valerio, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems